BP PLC
17 February 2006
The Company announces that on 16 February 2006, performance share awards
(Awards) were made to the following Executive Directors under the share element
of the BP Executive Directors' Incentive Plan (the Plan).
Director Max number of Ordinary Shares
in the Company under Award
Lord Browne 1,761,249
Dr D C Allen 383,200
Mr I C Conn 383,200
Dr A B Hayward 383,200
Mr J A Manzoni 383,200
Max number of ADSs under Award
Dr B E Grote 78,405
These shares pertain to the 2006-2008 performance period. The number of Shares/
ADSs set out above is the maximum number which may vest under the Award. The
actual number of Shares/ADSs which vest will depend on the extent to which
performance conditions have been satisfied over a three-year period ending 31
December 2008. These performance conditions remain as described in the summary
of the Plan set out in the Directors' Remuneration Report which is contained in
BP's Annual Report and Accounts 2004. In addition, each Director will be
entitled to additional Shares/ADSs representing the value of reinvested
dividends on those Shares/ADSs which vest.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.